Cargando…
Physical Activity, Weight, and Outcomes in Patients Receiving Chemotherapy for Metastatic Breast Cancer (C40502/Alliance)
BACKGROUND: Obesity and inactivity are associated with increased risk of cancer-related and overall mortality in breast cancer, but there are few data in metastatic disease. METHODS: Cancer and Leukemia Group B 40502 was a randomized trial of first-line taxane-based chemotherapy for patients with me...
Autores principales: | Ligibel, Jennifer A, Huebner, Luke, Rugo, Hope S, Burstein, Harold J, Toppmeyer, Debra L, Anders, Carey K, Ma, Cynthia, Barry, William T, Suman, Vera, Carey, Lisa A, Partridge, Ann H, Hudis, Clifford A, Winer, Eric P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103727/ https://www.ncbi.nlm.nih.gov/pubmed/33981951 http://dx.doi.org/10.1093/jncics/pkab025 |
Ejemplares similares
-
Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early breast cancer (Alliance A011401): study design
por: Ligibel, Jennifer A., et al.
Publicado: (2017) -
PAM50 gene signatures and breast cancer prognosis with adjuvant anthracycline- and taxane-based chemotherapy: correlative analysis of C9741 (Alliance)
por: Liu, Minetta C, et al.
Publicado: (2016) -
CALGB 40603 (Alliance): Long-Term Outcomes and Genomic Correlates of Response and Survival After Neoadjuvant Chemotherapy With or Without Carboplatin and Bevacizumab in Triple-Negative Breast Cancer
por: Shepherd, Jonathan H., et al.
Publicado: (2022) -
Clinical trial update: implications and management of residual disease after neoadjuvant therapy for breast cancer
por: Mayer, Erica L, et al.
Publicado: (2007) -
Polygenic Inheritance of Paclitaxel-Induced Sensory Peripheral Neuropathy Driven by Axon Outgrowth Gene Sets in CALGB 40101 (Alliance)
por: Chhibber, Aparna, et al.
Publicado: (2014)